Why Exclusive Patent Licenses Can Be More Valuable Than Owning Patents Outright

patent-definition-1Patents encapsulate the hopes and dreams of a company and many investors, CEOs, and inventors have a negative gut reaction about not “owning” their patents. For some reason, “owning” their patents is a deeply emotional issue, but it should not be.

Sophisticated investors recognize the benefits of exclusive licenses and many prefer exclusive licenses over the cost, hassle, and uncertainty of having a startup manage its own patent portfolio.

Exclusive licenses are regularly done by universities and other technology transfer offices, as well as by patent holders and patent finance companies. These agreements are the way technologies can be moved into the marketplace without burdening a startup company and while giving the patent owner participation in the success.[1]

A licensor will grant an exclusive license when it wants another company to bring a technology to market. The exclusivity gives the licensee the incentive to invest in developing the market potential of the technology.

In contrast, a non-exclusive license dis-incentivizes the licensee from investing in developing a market. This is because the licensor could sell licenses to all of the company’s competitors after the first licensee educates and cultivates the market for the product.

For a startup, having an exclusive license to a patent is actually more valuable than “owning” a patent.

Patents are a big capital investment for a startup company, but so is an office building. However, no startup company owns their office building outright. Even if they did own the building, they would take a mortgage on the building to free up capital. Exclusive licenses are the same thing as a lease agreement: the startup has full control of the assets, but does not have to spend capital to build or maintain the asset.

An Exclusive License Aligns Incentives

In a licensing agreement, the licensee and licensor have aligned incentives. Both parties want the licensee to be successful.

The patent holder has every incentive to have a good patent.

The patent holder’s only stock in trade is a quality patent. If the licensee cannot find any commercial value in the patent, the deal never gets done. It is incumbent on the patent holder to provide and maintain the highest quality patent possible.

Many licensing organizations, such as a select few of the major universities, have professional patent management systems in place. They professionally curate inventions and manage their portfolio to maximize the value to their licensees.[2]

When this is done well, the licensee startup company can benefit from professional patent management systems that they otherwise could not afford. Further, the licensor is incentivized to invest in the patents by paying for expedited costs, the additional costs for going up on appeal with the Patent Office, assistance in defending the patent from reexamination, or other costs that the startup can avoid.

An Exclusive License Eliminates Unpredictable Patent Costs

From a purely financial standpoint, an exclusive license reduces immediate patent costs and makes the costs predictable and manageable.

For a startup, unpredictable costs make for very difficult decisions. Should the CEO spend $4,000 on an office action response for the patent, or have a booth at a startup conference to attract investors? Which of these expenses will have the best return on investment for the company in the short term? Which expenses would be best in the long term?

In the analogy of owning the office building, a startup might be faced with an emergency roof repair, a plugged drain the bathroom, or repaving the parking lot. The unpredictable nature means that capital needs to be set aside to deal with the variability.

Unpredictable costs, such as patent costs, are managed by keeping a prudent reserve. The reserve can be managed explicitly, such as setting aside so many dollars for patent costs, or may be reactionary, where there is a churn of unpredictable expenses.

The prudent reserve – no matter how prudent – is still capital that cannot be deployed to grow the business. The more costs that can be predicted, the fewer reserves need to be set aside for the unpredictable costs, and the more capital can be fully deployed to advance the business.

Cost of Capital: Exclusive Licenses Make Financial Sense.

When capital is scarce, it is very expensive. Most startups are capital constrained to the point where they sell off huge chunks of equity in exchange for small amounts of cash. In fact, most angel and venture backed capital comes with a cost of capital on the order of 40% per year.[3]

With the capital costs outrageously high, it makes sense to pay as little as possible and still control an asset. This arrangement leverages someone else’s investment for the benefit of the company.

License fees are expenses and not an asset that needs to be capitalized.

Patent assets are often capitalized over 20 years, which is the lifetime of the assets. When a portfolio company pays a license fee, that fee is a direct expense and is not capitalized. Not only is the license fee less than they would have paid initially, but those fees come directly off the bottom line.

Operationally, Exclusive Licenses Can Give A Company More Flexibility

Most exclusive licenses allow a licensee to modify the arrangement at any time. Most agreements allow the licensee to terminate the agreement by merely not paying the license fees, while other agreements might have other ways of changing the agreements.

investing-in-patents-2A startup company may change focus, pivot, regroup, or find itself in a new market where their first patents are not useful. With a license agreement, the startup can often change the agreement without severe financial impact.

For example, an exclusive license agreement for a set of patents may allow the startup company to eliminate one or more patents from the agreement to reduce its costs. The licensor is taking a risk in that agreement, but giving the licensee more flexibility.

Many exclusive licenses allow for sublicensing.

Some exclusive licenses provide the option to sublicense the technology to another company.[4] Because the startup company has the exclusive license, the startup can often perform outbound licensing, such as sublicensing to competitors or spinout companies. This gives a startup company virtually the same business options as it would have had if they owned the patents outright.

Licensing agreements can have very creative payment arrangements.

Some license agreements may have different payment terms for different uses of the patents. For example, a university license agreement may include one percentage of gross revenues to be paid for products sold by the company but a different percentage for revenue received from sublicensing.

The allowable uses of the assets and the payments associated with those uses can be negotiating points when taking a license. The key for the startup licensee would be to determine their likely usage scenarios of the assets first, then negotiate favorable terms for the most important uses of the assets.

Many companies or universities that license technologies to startups can have very favorable terms for startups. For example, a startup may be able to negotiate zero payments for a period of time yet may still have the full control of the assets during that time. As the startup becomes profitable or meets certain milestones, the payment terms may change to still be affordable.

Many license agreements are transferrable.

Many license agreements are transferrable to another company, such as an acquiring company. Transferrable licenses can be just as valuable – if not more – than transferring the patents in some situations.

Other license agreements may terminate on certain events, such as the licensee itself being sold. Often, such agreements may provide that the acquiring company may take a license under the same terms as the first licensee, which effectively makes the license transferrable.

Some licenses are not transferrable. These can pose unwanted restrictions on a startup’s ability to exit, so these terms should be negotiated carefully.

License Arrangements Make A Company Immune To Lawsuits

An interesting side benefit of having patents in a separate entity is that the operating company is much less exposed to lawsuits.

Operating companies face many legal risks, from employment-related lawsuits to product liability lawsuits.

When patents are held in a separate company with separate control, a judgment from a lawsuit can never reach the patents. This means that a competitor, contractor, customer, employee, business partner, or anyone else cannot sue the company and hope to win the patents. This structure significantly reduces the attractiveness of the company from a plaintiff’s standpoint.

Exclusive patent licenses are well known and respected throughout industry.

Many startup companies and CEOs do not have direct experience with exclusive or non-exclusive licenses, but these types of agreements are well respected and enforceable.

A license agreement is merely a contract. In the contract, each party can spell out their terms for what they receive and what they give in return. The license agreement can contain provisions such as arbitration clauses, mechanisms to rectify late payments, and all sorts of other terms.

Because license agreements are contracts, they can be negotiated, drafted, and reviewed by conventional contracts attorneys and enforced in local state court. This makes the costs relatively manageable.

Note: This is an excerpt from “Investing In Patents” by Russ Krajec. Russ is CEO and founder of BlueIron IP, an investment company that finances patents for startup companies.


[1] Startups themselves may use exclusive licenses to give suppliers, vendors, competitors, or complementary businesses certain rights. An exclusive license may be narrowly focused, such as giving exclusive rights in a certain industry or geography.

[2] Sadly, most university technology transfer offices are woefully incompetent and do a very poor job. This is due to the fact that few understand the needs of the startup companies that the serve, as well as very poor internal incentives to close license deals.

[3] “Pepperdine Private Capital Markets Project, 2013 Capital Markets Report”. Cost of capital of venture capital: 38.2%, private equity: 25.0%, mezzanine funding: 18.5%, asset backed loans: 13.0%, and banks: 6.8%. Report available at: http://cerescom.net/index.php?page=valuing-private-businesses-2013.

[4] Not all exclusive licenses provide for sublicensing or cross-licensing options. Sometimes, these provisions can be limiting to a startup company, while other times not. It is important to know what restrictions – if any – come with the license agreement.


Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com. Read more.

Join the Discussion

3 comments so far.

  • [Avatar for Paul F. Morgan]
    Paul F. Morgan
    June 27, 2016 11:33 am

    I wish there WERE more successful exclusive licenses, especially from universities, to encourage more new product developments and businesses. However, I feel obligated to note another popular licencing myth. Namely, that selling or exclusively licensing a patent to another legal entity escapes patent litigation costs. Even if the original patent owner can avoid being a party to the lawsuit enforcement of the sold or licensed patent, they and their inventors are still subject to potential costly and time consuming third party document discovery and subpoenas for the majority of patent suit defense issues.

  • [Avatar for Paul F. Morgan]
    Paul F. Morgan
    June 26, 2016 10:48 am

    Re your comment that: “Sadly, most university technology transfer offices are woefully incompetent and do a very poor job.”
    In sympathy, besides hiring/salary constraints they many also have authority constraints relative to the influence of subject professors obtaining the research grants and weak administration controls.
    In particular, they may insist on legally disastrous contract provisions like “joint ownership” of patents. Many corporate and university representatives and their inventors not understanding what “jointly owned” means legally for patents. See, e.g., “Joint Ownership” of Inventions, Patents or Copyrights – A Legal mess to Avoid” December 1997 AUTM Newsletter [The Association of University Technology Managers.] Subsequent Fed. Cir. decisions confirm the unfortunate results of such a provision in university contracts, especially for “improvement” inventions, but it continues.
    Another university licensing problem has been legally inadequate university employment agreement invention assignment clauses. A prime example was in Board of Trustees of the Leland Stanford Jr. University v. Roche Molecular Systems, Inc., 583 F.3d 832, 841 (Fed. Cir. 2009) [Another issue in this case was finally decided at the Sup. Ct.]. This defective employee invention assignment licensing revenue disaster for Stamford, and the two ways it could have been avoided, is discussed in detail in the Jan./Feb. 2011 ABA IPL “LANDSLIDE” magazine starting on p.24.

  • [Avatar for Paul F. Morgan]
    Paul F. Morgan
    June 26, 2016 09:45 am

    There are some other factors to keep in mind. The patent owner may well not want to spend millions suing infringers, yet infringers may distroy the exclusivity benefit of the license to the licensee. Depending on the agreement, both parties may be required to sue jointly to enforce the patent. What happens when the validity of the patent claims is challenged in an IPR or reexamination? Even by the licensee itself, seeking to end royalty payments? What happens when the licensee changes its product and claims it no longer infringes the claims? What happens if the licensee goes bankrupt? Who controls and pays for U.S. and foreign patent prosecution decisions and the high foreign equivalent maintenance fees? Etc.